Rchr
J-GLOBAL ID:200901083176655365
Update date: Sep. 28, 2024
Matsuura Eiji
マツウラ エイジ | Matsuura Eiji
Affiliation and department:
Homepage URL (1):
http://www.crc.okayama-u.ac.jp/
Research field (6):
Metabolism and endocrinology
, Radiology
, Allergies and connective tissue disease
, Other
, Immunology
, Pathobiochemistry
Research keywords (6):
脂質代謝学
, 分子イメージング学
, 腫瘍生物学
, 臨床診断学
, 免疫学
, 生化学
Research theme for competitive and other funds (24):
- 2022 - 2026 Super流産の原因遺伝子の同定と胎児染色体正常原因不明習慣流産の病態解明
- 2018 - 2020 PET核種の光増感作用を活用し たセラノスティックスのための量子ドットナノマシン
- 2016 - 2019 Development of a novel imaging biomarker of Abeta oligomers in the brain
- 2016 - 2019 深部・転移がんへのRadioPhotoDynamic(RPD)・Theranosticsを実現する89Zr標識・抗体担持生分解性キャリアの開発
- 2016 - 2019 細胞膜・血液脳関門通過型Aβ オリゴマーマイクロ抗体による 新規PET画像診断の創出
- 2015 - 2018 Assessment of high functionality of Dioscorea japonica and development of dysphagia diet using the yam
- 2016 - 2018 深部病巣を標的とするTheranosticsに不可欠な新規放射線工学療法の開発
- 2015 - 2017 Imaging the antibody internalization by multiple-molecular simultaneous imaging for prediction of antibody-drug conjugates efficacy
- 2014 - 2017 動脈硬化性疾患の早期診断を可能にする分子イメージング・リピドーム解析技術の構築
- 2014 - 2016 Pathophysiology of life-related diseases with ectopic calcification: approaches for diagnostics and therapy
- 2014 - 2016 Theranosticsを実現する89Zr標識による新規抗体・DDSキャリアの開発
- 2012 - 2015 新規核種(89Zr)による抗体PETプローブの開発
- 2013 - 2015 Development of a PET imaging system for cancer diagnosis using Zr-89 lableled anti-mesothelin scFv
- 2011 - 2014 線溶系代謝物を用いる病原性血管新生の標的医療(画像診断と同時治療法)の開発
- 2011 - 2013 特異抗体によるがんの標的医療(画像診断と同時治療法)の開発
- 2010 - 2012 evaluation of plaque vulnerability by plasma oxidized LDL
- 2008 - 2010 Physiological role of 11-dehydrothromboxane B2 : parameter of platelet activity and aspirin resistance
- 2006 - 2007 Pathobiochemical and immunological study on infection-accelerated atherosclerosis and its regulation.
- 2005 - 2006 Study of anti-laminin-1 autoantibodies in endometriosis-associated infertility
- 2004 - 2005 "タンパク質"修飾酸化LDLの診断法の確立と動脈硬化における意義に関する研究
- 2002 - 2003 A role of macrophages on antiphospholipid syndrome : antigen presenting and mechanisms on thrombosis
- 1998 - 1998 抗リン脂質抗体の関与する動脈硬化の発症機序の解明
- 1996 - 1996 発生工学を応用したα-フェトプロティンの糖鎖構造および機能の解析
- 1995 - 1996 Establishment of a novel assay method for anticardiolipin antibodies.
Show all
Papers (291):
-
Zbigniew J. Leśnikowski, Filip Ekholm, Narayan S. Hosmane, Martin Kellert, Eiji Matsuura, Hiroyuki Nakamura, Agnieszka B. Olejniczak, Luigi Panza, Louis M. Rendina, Wolfgang A. G. Sauerwein. Early Stage In Vitro Bioprofiling of Potential Low-Molecular-Weight Organoboron Compounds for Boron Neutron Capture Therapy (BNCT)-Proposal for a Guide. Cells. 2024. 13. 10. 798-798
-
Andisyah Putri Sekar, Septia Nurmala, Eiji Matsuura, Xian Wen Tan, Ratika Rahmasari, Rani Sauriasari. Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions. Breast Cancer: Basic and Clinical Research. 2024. 18
-
Wolfgang A.G. Sauerwein, Thomas Fischer, Lucie Sancey, Camille Verry, Eiji Matsuura, Raymond L. Moss, Andrea Wittig. Principles, Recent Developmentsand Perspectives in Boron NeutronCapture Therapy (BNCT). Bio-Algorithms and Med-Systems. 2023. 19. 1. 48-53
-
田中 七星, 渡邉 和則, 小渕 浩嗣, 久保 貴紀, 松浦 栄次, 大槻 高史. 効率的なsiRNAの光依存的細胞内送達能を持つ生分解性ナノキャリアの開発. 日本バイオマテリアル学会大会予稿集. 2022. 44回. 325-325
-
Abdul Basith Fithroni, Kazuko Kobayashi, Hirotaka Uji, Manabu Ishimoto, Masaru Akehi, Takashi Ohtsuki, Eiji Matsuura. Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect. Cells. 2022. 11. 20
more...
MISC (25):
-
井上晴喜, FITHRONI Abdul Basith, 渡邉和則, 松浦栄次, 大槻高史. Development of biodegradable micellar boron preparation for BNCT Therapy. 日本バイオマテリアル学会大会予稿集(Web). 2023. 45th
-
井出将博, 井出将博, 三嶋隆, 吉田泉, 高橋有志, 熊谷百慶, 五十嵐友二, 松浦栄次. ニトベギク由来オリザビンはPMA刺激ヒト単球THP-1細胞のPTEN発現を促進しAktリン酸化とCD36の発現を抑制する. 日本栄養・食糧学会大会講演要旨集. 2019. 73rd
-
井出将博, 井出将博, 熊谷百慶, 三嶋隆, 吉田泉, 高橋有志, 中村宗知, 松浦栄次. ニトベギク茎葉由来orizabinのヒト臍帯静脈内皮細胞とヒト単球細胞THP1における細胞接着と泡沫化の抑制作用. 日本生化学会大会(Web). 2018. 91st
-
Toshiki Kobayashi, Kohei Kawata, Mariko Nakayama, Yuki Furusawa, Shoya Yamada, Hiroyuki Hirano, Fumiaki Takenaka, Masaru Akehi, Takanori Sasaki, Eiji Matsuura, et al. Elucidation of the pharmacokinetic difference of regioisomeric retinoid X receptor agonists having an alkoxy group by PET imaging. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2014. 248
-
T. Sasaki, Y. Matsunami, F. Takenaka, S. Kita, H. Hirano, L. Shen, K. Kobayashi, E. Matsuura. SIGNIFICANT ACCUMULATION OF OXLDL/BETA2-GLYCOPROTEIN I COMPLEXES IN ARTERIAL LESIONS OF WHHL RABBITS: PET/CT IMAGING USING AN AUTO ANTIBODY'S SCFV VARIANT. ATHEROSCLEROSIS. 2014. 235. 2. E68-E68
more...
Patents (27):
-
日本語出願
-
遺伝子導入りンハ球の移植仁よる細胞療法1、おける治療 効果及びGVHDを可視化するPETイメージング技術
-
DNA、ポリペプチド、抗メソセリン抗体、腫瘍イメージング剤及び複合体
-
放射性同位元素製造装置
-
89Zrの標識方法、及び89Zrの標識装置
more...
Books (124):
-
新規モダリティ医薬品
2023
-
Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect
MDPI AG 2022
-
Role of urinary H2O2, 8-iso-PGF2α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease
2022
-
Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice
Elsevier 2022
-
Lactosome-Conjugated siRNA Nanoparticles for Photo-Enhanced Gene Silencing in Cancer Cells
Elsevier BV 2021
more...
Lectures and oral presentations (218):
-
ニトベギク由来オリザビンはPMA刺激ヒト単球THP-1細胞のPTEN発現を促進しAktリン酸化とCD36の発現を抑制する
(日本栄養・食糧学会大会講演要旨集 2019)
-
A novel single chain valiant of antibody (scFv) against mesothelin (MSLN) established by phage library for PET imaging
(World Mol Imaging Conference, Seattle, USA 2018)
-
roteolysis-resistant domains in β2-glycoprotein I (β2GPI): Features and potent applications in lipidomics
(nternational Congress on Autoimmunity, Lisbon, Portugal 2018)
-
Autoimmunity and angiogenesis
(International Congress on Autoimmunity, Lisbon, Portugal 2018)
-
New era of in vivo molecular imaging and targeted medical care: Antibody-based theranostics
(NewYork Pharma Forum (NYPF) , New York、USA 2018)
more...
Education (1):
- - 1984 Okayama University Graduate School, Division of Pharmaceutical Sciences
Professional career (2):
- 博士(医学) (岡山大学)
- 修士(薬学) (岡山大学)
Work history (12):
- 2023/04 - 現在 Okayama University Special Appointed Professor, Professor Emeritus
- 2017/04 - 2023/03 Okayama University Neutron Therapy Research Center
- 2011/01 - 2023/03 Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences
- 2017 - - Professor,Neutron Medical Research Center,Okayama University
- 2007/04 - 2011/01 岡山大学医歯薬学総合研究科病態制御科学専攻病態機構学講座(細胞化学分野)准教授
- 2007 - 2011 Associate Professor,Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University
- 2001/04 - 2007/03 岡山大学大学医学部附属分子細胞医学研究施設 細胞工学部門 助教授
- 1997/05 - 2001/03 岡山大学医学部附属分子細胞医学研究施設細胞工学部門 講師
- 1995/11 - 1997/04 北海道大学医学部生化学第一講座 助手
- 1988/11 - 1995/10 ヤマサ醤油(株)診断薬部免疫研究室 主任研究員
- 1986/09 - 1988/11 Department of Pediatrics and Medicine, National Jewish Center for Immunology and Respiratory Medicine (affiliated to Colorado University Health Science Center), Denver, CO, USA, Research Associate
- 1985/04 - 1986/08 Okayama University Faculty of Pharmaceutical Sciences
Show all
Awards (7):
Association Membership(s) (9):
おかやまバイオアクティブ研究会
, 岡山県医用工学研究会
, International Conference on Mechanics in Medicine and Biology (ICMMB)
, World Molecular Imaging Society (WMIS)
, 日本癌学会
, 日本核医学会
, 日本リウマチ学会
, 日本生化学会
, 日本免疫学会
Return to Previous Page